BridgeMD
New treatment option for Human Papillomavirus Infection
Official title Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
ClinicalTrials.gov ID: NCT06598475
What this study is testing
- What it's testing
- The purpose of this study is to determine the provider- and practice-level characteristics that influence the impact of implementation strategies guided by practice facilitation in each clinical practice, to test whether the facilitator-driven provider- and practice-level implementation strategies increase provider recommendations and Human Papilloma Virus (HPV) vaccination rates and to evaluate implementation and future sustainability of the facilitator-driven implementation strategies across nine clinical practice sites
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 11 to 17
You may be able to join if
- FQHC's with less than 60% HPV vaccine initiation rate for 11-12 year old adolescents overall at their practice sites
- FQHC's that have family medicine and/or pediatric practices
- a total adolescent patient population at least 50% Latino
- be willing for Health Care Provider (HCP) and staff members to receive education, training, and support; complete standardized measurement, and agree...
- Providers, aged 18 and over, employed at each FQHC (4 staff per practice)
You likely can't join if
- -FQHCs that participated in the pilot study were excluded.
See the full eligibility criteria
- FQHC's with less than 60% HPV vaccine initiation rate for 11-12 year old adolescents overall at their practice sites
- FQHC's that have family medicine and/or pediatric practices
- a total adolescent patient population at least 50% Latino
- be willing for Health Care Provider (HCP) and staff members to receive education, training, and support; complete standardized measurement, and agree to randomization.
- Providers, aged 18 and over, employed at each FQHC (4 staff per practice)
- Staff, aged 18 and over, employed at each FQHC (5 staff per practice)
- Implementation team members (i.e., administrative designee, health care providers, immunization navigators, and other staff), aged 18 and over, employed at each FQHC (4 members per practice)
- Parents (aged 18 and over) of patients ages 11-17 seeking care at each FQHC (25 per practice).
- -FQHCs that participated in the pilot study were excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 11 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.